{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:23:57Z","timestamp":1784165037813,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["4021137"],"award-info":[{"award-number":["4021137"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mcp.2025.102048","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T06:25:35Z","timestamp":1756535135000},"page":"102048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Non-coding RNAs in chronic lymphocytic leukemia: A systematic review and meta-analysis to decode the diagnostic potential"],"prefix":"10.1016","volume":"84","author":[{"given":"Amir Hossein","family":"Aghayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Haddadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Atashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.mcp.2025.102048_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib3","first-page":"49","article-title":"Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia","volume":"49","author":"Thurmes","year":"2008"},{"issue":"10129","key":"10.1016\/j.mcp.2025.102048_bib4","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0140-6736(18)30422-7","article-title":"Chronic lymphocytic leukaemia","volume":"391","author":"Hallek","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcp.2025.102048_bib5","first-page":"455","article-title":"Diagnostic and therapeutic recommendations of the polish society of haematologists and transfusiologists and polish adult leukemia group-CLL for chronic lymphocytic leukemia in 2021","volume":"52","author":"Hus","year":"2021"},{"key":"10.1016\/j.mcp.2025.102048_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fonc.2019.00079","article-title":"Time to treatment prediction in chronic lymphocytic leukemia based on new transcriptional patterns","volume":"9","author":"Mosquera Orgueira","year":"2019","journal-title":"Front. Oncol."},{"issue":"18","key":"10.1016\/j.mcp.2025.102048_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186720","article-title":"Non-coding RNAs as cancer hallmarks in chronic lymphocytic leukemia","volume":"21","author":"Fabris","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mcp.2025.102048_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10059-011-1004-8","article-title":"The coded functions of noncoding RNAs for gene regulation","volume":"31","author":"An","year":"2011","journal-title":"Mol. Cells"},{"issue":"2","key":"10.1016\/j.mcp.2025.102048_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020168","article-title":"Non-coding RNAs: the \u201cdark side matter\u201d of the CLL universe","volume":"14","author":"Lingua","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"23","key":"10.1016\/j.mcp.2025.102048_bib10","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1182\/blood-2009-07-192740","article-title":"Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes","volume":"114","author":"Calin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.mcp.2025.102048_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-42059-2_1","article-title":"Non-coding RNAs: classification, biology and functioning","volume":"937","author":"Hombach","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"17","key":"10.1016\/j.mcp.2025.102048_bib12","first-page":"1793","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005"},{"issue":"2","key":"10.1016\/j.mcp.2025.102048_bib13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jcp.25799","article-title":"State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia","volume":"233","author":"Mirzaei","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.mcp.2025.102048_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-015-0112-x","article-title":"Role of microRNA in chronic lymphocytic leukemia onset and progression","volume":"8","author":"Balatti","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31557\/APJCP.2021.22.1.111","article-title":"Diagnostic value of plasma miR-145 and miR-185 as targeting of the APRIL oncogene in the B-cell chronic lymphocytic leukemia","volume":"22","author":"Bagheri","year":"2021","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.mcp.2025.102048_bib16","doi-asserted-by":"crossref","unstructured":"B. Uszczynska-Ratajczak, et al., Towards a complete map of the human long non-coding RNA transcriptome. 2018. 19(9): p. 535-548.","DOI":"10.1038\/s41576-018-0017-y"},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib17","first-page":"27","article-title":"The role of long non\u2010coding RNAs and downstream signaling pathways in leukemia progression","volume":"39","author":"Liu","year":"2021"},{"issue":"3","key":"10.1016\/j.mcp.2025.102048_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/ijlh.13167","article-title":"Upregulation of long noncoding RNA Lnc-IRF2-3 and Lnc-ZNF667-AS1 is associated with poor survival in B-chronic lymphocytic leukemia","volume":"42","author":"El-Khazragy","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.mcp.2025.102048_bib19","first-page":"109","volume":"vol. 7","author":"Perez de Acha","year":"2020"},{"issue":"3","key":"10.1016\/j.mcp.2025.102048_bib20","first-page":"919","article-title":"Circ-RPL15: a plasma circular RNA as novel oncogenic driver to promote progression of chronic lymphocytic leukemia","volume":"34","author":"Wu","year":"2020"},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2018.06.045","article-title":"Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607\/FZD3\/Wnt\/\u03b2-catenin pathway","volume":"503","author":"Xia","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mcp.2025.102048_bib22","article-title":"circZNF91 promotes the malignant phenotype of chronic lymphocytic leukemia cells by targeting the miR-1283\/WEE1 Axis","volume":"2022","author":"Li","year":"2022","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.1016\/j.mcp.2025.102048_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051554","article-title":"Circular RNA expression signatures provide promising diagnostic and therapeutic biomarkers for chronic lymphocytic leukemia","volume":"15","author":"Gharib","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mcp.2025.102048_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172976","article-title":"Expression of non-coding RNAs in hematological malignancies","volume":"875","author":"Ghafouri-Fard","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mcp.2025.102048_bib25","series-title":"The PRISMA 2020 Statement: an Updated Guideline for Reporting Systematic Reviews","first-page":"372","author":"Page","year":"2021"},{"key":"10.1016\/j.mcp.2025.102048_bib26","first-page":"1","volume":"vol. 5","author":"Ouzzani","year":"2016"},{"issue":"8","key":"10.1016\/j.mcp.2025.102048_bib27","first-page":"529","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011"},{"key":"10.1016\/j.mcp.2025.102048_bib28","series-title":"Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy","author":"Deeks","year":"2023"},{"issue":"4","key":"10.1016\/j.mcp.2025.102048_bib29","first-page":"203","article-title":"Measures of diagnostic accuracy: basic definitions","volume":"19","author":"\u0160imundi\u0107","year":"2009","journal-title":"Ejifcc"},{"key":"10.1016\/j.mcp.2025.102048_bib30","series-title":"Netter's Orthopaedic Clinical Examination: an Evidence-Based Approach","author":"Cleland","year":"2015"},{"issue":"2","key":"10.1016\/j.mcp.2025.102048_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jclinepi.2010.01.009","article-title":"Combining heterogenous studies using the random-effects model is a mistake and leads to inconclusive meta-analyses","volume":"64","author":"Al Khalaf","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.mcp.2025.102048_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2046545","article-title":"MicroRNA-155-5p overexpression in peripheral blood mononuclear cells of chronic lymphocytic leukemia patients is a novel, independent molecular biomarker of poor prognosis","volume":"2017","author":"Papageorgiou","year":"2017","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12288-018-1000-7","article-title":"Study of microRNA profile as a molecular biomarker in Egyptian chronic lymphocytic leukemia","volume":"35","author":"Farahat","year":"2019","journal-title":"Indian J. Hematol. Blood. Transfus."},{"issue":"3","key":"10.1016\/j.mcp.2025.102048_bib34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/10428194.2018.1461861","article-title":"MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia","volume":"60","author":"Papageorgiou","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.mcp.2025.102048_bib35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.omto.2020.01.004","article-title":"Differential expression profile of miR-27b, miR-29a, and miR-155 in chronic lymphocytic leukemia and breast cancer patients","volume":"16","author":"Raeisi","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s43046-021-00097-x","article-title":"Prognostic significance of microRNA 17-92 cluster expression in Egyptian chronic lymphocytic leukemia patients","volume":"33","author":"Khalifa","year":"2021","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"10.1016\/j.mcp.2025.102048_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106691","article-title":"Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia","volume":"111","author":"Rahimi","year":"2021","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.mcp.2025.102048_bib38","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12581","article-title":"Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations","volume":"25","author":"Grenda","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.mcp.2025.102048_bib39","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.31557\/APJCP.2023.24.7.2439","article-title":"Prognostic value of plasma miR-29a evaluation in chronic lymphocytic leukemia patients","volume":"24","author":"Aref","year":"2023","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"34","key":"10.1016\/j.mcp.2025.102048_bib40","article-title":"m6A-Modified circTET2 interacting with HNRNPC regulates fatty acid oxidation to promote the proliferation of chronic lymphocytic leukemia","volume":"10","author":"Wu","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib41","first-page":"329","article-title":"The American society of hematology education program book","volume":"2017","author":"Gaidano","year":"2017","journal-title":"Mutat. Landsc. Chron. Lymphocytic Leukemia Impact Prognosis Treat."},{"key":"10.1016\/j.mcp.2025.102048_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1146486","article-title":"Precision diagnostics in chronic lymphocytic leukemia: past, present and future","volume":"13","author":"Mollstedt","year":"2023","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.mcp.2025.102048_bib43","first-page":"1621","article-title":"Immunophenotyping of chronic lymphocytic leukemia","volume":"63","author":"Falay","year":"2017","journal-title":"Clin. Lab."},{"issue":"8","key":"10.1016\/j.mcp.2025.102048_bib44","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","article-title":"Flow cytometric immunophenotyping for hematologic neoplasms","volume":"111","author":"Craig","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cyto.b.21595","article-title":"Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) & European society for Clinical Cell Analysis (ESCCA) harmonisation project","volume":"94","author":"Rawstron","year":"2018","journal-title":"Cytometry B Clin. Cytom."},{"issue":"4","key":"10.1016\/j.mcp.2025.102048_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000707","article-title":"Cytogenetics in chronic lymphocytic leukemia: ERIC perspectives and recommendations","volume":"6","author":"Baliakas","year":"2022","journal-title":"Hemasphere"},{"issue":"5","key":"10.1016\/j.mcp.2025.102048_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11050853","article-title":"The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment","volume":"11","author":"P\u00e9rez-Carretero","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.mcp.2025.102048_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1755-8166-3-17","article-title":"Fluorescence in situ hybridization in combination with the comet assay and micronucleus test in genetic toxicology","volume":"3","author":"Hovhannisyan","year":"2010","journal-title":"Mol. Cytogenet."},{"issue":"41","key":"10.1016\/j.mcp.2025.102048_bib49","doi-asserted-by":"crossref","first-page":"71234","DOI":"10.18632\/oncotarget.19525","article-title":"Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons","volume":"8","author":"Rodr\u00edguez-Vicente","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.mcp.2025.102048_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000962","article-title":"All-CLL: a capture-based next-generation sequencing panel for the molecular characterization of chronic lymphocytic leukemia","volume":"7","author":"L\u00f3pez-Oreja","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.mcp.2025.102048_bib51","volume":"875","author":"Ghafouri-Fard","year":"2020"},{"key":"10.1016\/j.mcp.2025.102048_bib52","first-page":"94","volume":"vol. 2","author":"Heuston","year":"2011"},{"issue":"12","key":"10.1016\/j.mcp.2025.102048_bib53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.21037\/atm.2018.06.10","article-title":"Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer","volume":"6","author":"Diamantopoulos","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-020-01175-9","article-title":"Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance","volume":"19","author":"Bhat","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mcp.2025.102048_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.critrevonc.2019.02.008","article-title":"MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations","volume":"136","author":"Rashed","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.mcp.2025.102048_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211033061","article-title":"The potential diagnostic accuracy of circulating MicroRNAs for leukemia: a meta-analysis","volume":"20","author":"Zhang","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12935-023-03028-z","article-title":"CircRNAs in diagnosis, prognosis, and clinicopathological features of multiple myeloma; a systematic review and meta-analysis","volume":"23","author":"Mirazimi","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.mcp.2025.102048_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23303","article-title":"Appraising circular RNAs as novel biomarkers for the diagnosis and prognosis of gastric cancer: a pair-wise meta-analysis","volume":"34","author":"Chen","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.mcp.2025.102048_bib59","article-title":"Systematic review with meta-analysis: diagnostic, prognostic and clinicopathological significance of CircRNA expression in renal cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13643-019-1131-4","article-title":"An algorithm for the classification of study designs to assess diagnostic, prognostic and predictive test accuracy in systematic reviews","volume":"8","author":"Mathes","year":"2019","journal-title":"Syst. Rev."},{"issue":"11","key":"10.1016\/j.mcp.2025.102048_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae640","article-title":"Improving ncRNA family prediction using multi-modal contrastive learning of sequence and structure","volume":"40","author":"Xu","year":"2024","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.mcp.2025.102048_bib62","first-page":"1679","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021"},{"issue":"12","key":"10.1016\/j.mcp.2025.102048_bib63","first-page":"2045","article-title":"An update on flow cytometry analysis of hematological malignancies: focus on standardization","volume":"17","author":"Holl","year":"2025"},{"key":"10.1016\/j.mcp.2025.102048_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/435983","article-title":"Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go","volume":"2014","author":"Puiggros","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.mcp.2025.102048_bib65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00776-007-1215-1","article-title":"Advantages and limitations of cytogenetic, molecular cytogenetic, and molecular diagnostic testing in mesenchymal neoplasms","volume":"13","author":"Bridge","year":"2008","journal-title":"J. Orthop. Sci."},{"issue":"3","key":"10.1016\/j.mcp.2025.102048_bib66","article-title":"Cytogenetics in the management of hematological malignancies: an overview of alternative technologies for cytogenetic characterization","volume":"72","author":"Lestringant","year":"2024","journal-title":"Curr. Res. Transl. Med."},{"issue":"2","key":"10.1016\/j.mcp.2025.102048_bib67","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4274\/tjh.2017.0085","article-title":"The role of CD200 and CD43 expression in differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma","volume":"35","author":"Falay","year":"2018","journal-title":"Turk. J. Haematol."},{"issue":"1","key":"10.1016\/j.mcp.2025.102048_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010055","article-title":"Treatment of chronic lymphocytic leukemia in the personalized medicine era","volume":"16","author":"S\u00e1nchez Su\u00e1rez","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.mcp.2025.102048_bib69","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/bjh.15877","article-title":"Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments","volume":"185","author":"Hu","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.mcp.2025.102048_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.77","article-title":"lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome","volume":"6","author":"Ronchetti","year":"2016","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.mcp.2025.102048_bib71","first-page":"1153","volume":"26","author":"Tosic","year":"2025","journal-title":"High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia"}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850825000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850825000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:23:59Z","timestamp":1772853839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850825000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":71,"alternative-id":["S0890850825000416"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2025.102048","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs in chronic lymphocytic leukemia: A systematic review and meta-analysis to decode the diagnostic potential","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2025.102048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102048"}}